On October 8, XUNCE fell 5.05% in regular trading to HK$85.6, with turnover of HK$72.37 million. The decline came as the stock extended profit-taking after shareholders unanimously approved a plan to invest up to RMB12 billion in an AI inference and computing center, alongside a maximum RMB10 billion syndicated loan. The heavy-asset expansion, financial leverage, and rigid capital spending have raised concerns over cash flow pressure.

The company reported first-half revenue up 389% year-on-year to RMB967 million, swinging to a profit, while JPMorgan recently initiated coverage with an Overweight rating and a HK$160 target price. However, the scale of the investment relative to XUNCE's current valuation has prompted some investors to lock in gains.

XUNCE is a China-based provider of real-time data infrastructure and analytics solutions, serving asset managers across portfolio monitoring, order execution, valuation, risk management, and compliance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)